The inhibitory effect of ascorbic acid on Campylobacterjejuni is described. In vitro growth of clinical strains, as measured spectrophotometrically, was inhibited by 0.5 mg of freshly prepared L-ascorbic acid per ml. Alkaline-treated or aged Lascorbic acid increased inhibition, as did copper; however, L-cysteine, L-cystine, and glutathione prevented inhibition. Biochemical analysis of the medium and cultures indicated that one or more of the oxidation products of L-ascorbic acid, e.g., L-dehydroascorbic acid or L-diketogulonic acid, were more effective inhibitors than was reduced L-ascorbic acid.
The inhibitory effect of ascorbic acid on Campylobacterjejuni is described. In vitro growth of clinical strains, as measured spectrophotometrically, was inhibited by 0.5 mg of freshly prepared L-ascorbic acid per ml. Alkaline-treated or aged Lascorbic acid increased inhibition, as did copper; however, L-cysteine, L-cystine, and glutathione prevented inhibition. Biochemical analysis of the medium and cultures indicated that one or more of the oxidation products of L-ascorbic acid, e.g., L-dehydroascorbic acid or L-diketogulonic acid, were more effective inhibitors than was reduced L-ascorbic acid.
Although ascorbic acid has been studied extensively in many laboratories, its metabolic functions in many biological systems remain obscure. It has been reported that ascorbic acid inhibits tubercle bacilli (5) . Because of the labile nature of ascorbic acid, its active form is often difficult to identify. However, it can be studied by examining the effects of compounds that reverse or prevent the inhibitory effect of ascorbic acid. We showed in vitro that Campylobacterjejuni, a diarrhea-producing agent in humans, is protected from the deleterious action of H202 by low concentrations of ascorbic acid and is inhibited by higher concentrations. The inhibitory concentrations of ascorbic acid were determined, and the effects of aging, pH, and trace amounts of copper on this inhibitory effect were studied as well.
MATERIALS AND METHODS Organisms. The C. jejuni strains used in this investigation were isolated from patients with diarrhea. They were characterized as slender, curved, gram-negative bacteria that were motile, produced catalase and H2S, and grew well at 37 to 42°C.
Culture conditions. To test the effect of ascorbic acid and other biochemical agents on C. jejuni, a yeast extract medium was used (3) . In addition to yeast extract, this medium contained 0.5% NaCl, which has been determined to be the ideal concentration for C. jejuni growth (2) . The effects of ascorbic acid and the other biochemical agents on C. jejuni growth were measured after incubation in a candle jar at 37°C; these culture conditions allowed for greater sensitivity to ascorbic acid or its antagonists. All Preparation of biochemical agents. L-Ascorbic acid (reagent grade; Fisher Scientific Co., Fairlawn, N.J.) stock solutions were prepared in distilled water (final concentration, 15 mg/ml), and the pH was adjusted to 6.0 with 6 N NaOH. All stock solutions were filter sterilized.
To determine the effect of pH on inhibition, the ascorbic acid was prepared in phosphate buffer (0.067 M Na2HPO4-0.067 M KH2PO4) at pH values from 5.5 to 8.0.
Sulfur-containing compounds utilized to interfere with ascorbic acid inhibition of C. jejuni cultures were prepared in distilled water, adjusted to pH 6, and filter sterilized. DL-Methionine, L-cysteine hydrochloride, L-cystine, dithiothreitol, and glutathione were purchased from Sigma Chemical Co., St. Louis, Mo.
Cupric sulfate (CuS04 * 5H20; certified, Fisher Scientific Co.), was added to yeast extract medium at 5, 10, 20, and 40 ppm (5, 10, 20, and 40 ,ul/liter).
Biochemical analysis. Total ascorbic acid was determined by following hydrazone formation with 2,4-dinitrophenylhydrazine, and the ascorbic acid in the reduced form was determined by following reduction of 2,6-dichlorophenolindophenol (6). This hydrazone reaction enabled determination of the total ascorbic acid in the forms of reduced L-ascorbic acid, Ldehydroascorbic acid, and L-diketogulonic acid. Nonspecific reduction of the dye by interfering substances was determined by diluting the specimen with freshly prepared ascorbate oxidase (Sigma Chemical Co.) in 0.05 M phosphate buffer, pH 5.6 (7). All specimens were stored at -60°C and diluted with 5% trichloroacetic acid immediately before assay to the linear concentration range (0 to 20 ,ug/ml) of the two meth-ods. In the reduction reaction, turbidity in the specimen was corrected by adding excess ascorbic acid to decolorize the indicator dye and measuring the background absorbance due to turbidity.
RESULTS
Ascorbic acid concentrations .0.5 mg/ml (.2.8 x 10-3 M) suppressed or completely inhibited growth. After 48 h of incubation, 76 and 11% of the cells were inhibited by 0.5 and 0.25 mg/ml, respectively (Fig. 1) . At a low concentration (0.031 mg/ml), ascorbic acid stimulated C. jejuni growth.
The effect of H202 on ascorbic acid inhibition is shown in Fig. 2 . Hydrogen peroxide at 0.0015 to 0.003% (vol/vol) inhibited C. jejuni growth. Ascorbic acid at 0.25 mg/ml reduced the inhibitory effect of 0.003% H202 by 50%.
The effect of alkaline-treated ascorbic acid (0.5 mg/ml) is shown in Fig. 3 . Of the ascorbic acid stock solutions (180 mg/ml) adjusted to pH values of 4.3, 5.2, 6.0, 7.0, and 8.5 and subsequently added to yeast extract medium with a resultant pH of 6.0 to 6.6, the solutions with a high pretreatment pH inhibited C. jejuni growth for 48 h most effectively.
To determine the effect of pH on the growth of C. jejuni in yeast extract medium without ascorbic acid, the medium was adjusted to pH values of 5.0 to 8.5. C. jejuni growth at pH values of <5.5 and >7.5 was inhibited at 72 h (Fig. 4) fresh ascorbic acid. Ascorbic acid aged 5 days before inoculation caused the pH to drop 0.5 units (Table 1 ). This did not affect growth in this medium (Fig. 4) . Organisms inoculated into the medium containing ascorbic acid aged 2 to 5 days showed no viability upon subculture after a 48-h incubation. In the uninoculated medium, total ascorbic acid (L-ascorbic acid, L-dehydroascorbic acid, and L-diketogulonic acid) determined by following the hydrazone reaction was found to have a half-life of 2 days. From freshly prepared ascorbic acid solutions in yeast extract medium, 93% of the added ascorbic acid was recovered in the hydrazone reaction; twothirds of this total ascorbic acid was determined to be in the reduced form.
The effect of reducing substances on ascorbic acid inhibition was studied. At 48 h, ascorbic acid concentrations of 0.5 mg/ml caused 88% growth inhibition. Without ascorbic acid, Lcysteine hydrochloride at 0 to 62 ,ug/ml in yeast extract medium did not cause any growth inhibition; however, when 15 and 31 ,ug/ml were added to yeast extract medium containing 0.5 mg of ascorbic acid per ml, inhibition was reduced to 83 and 33%, respectively. Total reversal of ascorbic acid inhibition was obtained at Lcysteine hydrochloride concentrations of 62 ,ug/ml. Similar reversal of inhibition was observed for cystine and glutathione. DL-Methionine and dithiothreitol did not reverse ascorbic acid inhibition.
To determine whether it was ascorbic acid in reduced form or its oxidation products that inhibited growth, copper was added to yeast extract medium. The presence of copper enhanced inhibition produced by freshly prepared L-ascorbic acid (Table 2) . We found that 5 ppm of copper (5 ,ug/ml; 20 ppm of CuSO4 * 5H20) increased ascorbic acid (0.125 mg/ml) inhibition of C. jejuni from 8 to 84%. (1) . Our current study demonstrates the inhibitory effect of ascorbic acid on in vitro growth of C. jejuni. The results suggest that growth of C. jejuni is inhibited primarily through ascorbic acid oxidation products: both aged and alkaline-treated ascorbic acid solutions were more effective than a freshly prepared ascorbic acid solution at inhibiting growth. The reducing substances which protect ascorbic acid from oxidation, cysteine, cystine, and glutathione, concomitantly reduced or prevented inhibition.
Copper, which catalyzes the oxidation of ascorbic acid, was found to increase the ascorbic acid inhibitory effect. Sutcliffe Ascorbic acid interfered with H202-produced inhibition of C. jejuni growth. This reversal of the inhibitory effect of H202 at low concentrations of ascorbic acid could have been due to the reduction of H202 by ascorbic acid or could have been similar to the quenching effect of norepinephrine and a combination of ferrous (4) . On the basis of the results of this study, it can be concluded that ascorbic acid inhibition of C. jejuni is caused by one or more of the oxidation products of ascorbic acid, such as L-dehydroascorbic acid or L-diketogulonic acid, rather than by reduced L-ascorbic acid. Additional studies are in progress to determine the active form of the inhibitory compound.
